Read + Share
Shu L, Wang D, Nannapaneni S, Sun Y, et al. Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and
neck squamous cell carcinoma cancer (HNSCC). Oral Oncol 2021;122:105546.
PMID: 34700281
|
 |
|
Shu L, Wang D, Nannapaneni S, Sun Y, et al. Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and
neck squamous cell carcinoma cancer (HNSCC). Oral Oncol 2021;122:105546.
PMID: 34700281
|
|
|
|